Ingo Uttner

Prof. Dr. Ingo Uttner


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2012 in European Neurology
Verified
Journal Article
Closed access
IUIngo Uttner
Ingo Uttner
SPSascha Prexl
Sascha Prexl
WFWolfgang Freund
Wolfgang Freund
AUAlexander Unrath
Alexander Unrath
DBDietmar Bengel
Dietmar Bengel
RHRoman Huber
Roman Huber
Focal hippocampal diffusion-weighted imaging (DWI) lesion patterns are detected in transient global amnesia (TGA) patients in different frequency. It has been speculated that acute diffusion restrictions are associated with a worse outcome. Therefore, we evaluated the influence of acute DWI lesions on the cognitive long-term outcome in TGA patients. Seventeen otherwise healthy patients with the clinical syndrome of TGA, who had MRI investigations on admission as well as 1 day later, were investigated with a comprehensive neuropsychological test battery 2 years later. Acute hippocampal DWI lesions in TGA patients were detected in almost two thirds of the patients. Psychometric evaluation revealed no differences in cognitive performance between patients with and without DWI lesions as well as compared to healthy subjects. In addition, no relapse of the attack has been recognized in either group of TGA patients.

30 September 2015 in BMC Neurology
Verified
Journal Article
Open access
PDF file
SFSusanne Fauser
Susanne Fauser
IUIngo Uttner
Ingo Uttner
HAHelena Ariño
Helena Ariño
WSWerner A. Scherbaum
Werner A. Scherbaum
ASAlbert Saiz
Albert Saiz
JLJan Lewerenz
Jan Lewerenz
In the pathogenesis of limbic encephalitis other promoting factors besides the pure existence of autoantibodies are increasingly discussed to play a significant role. This is to our knowledge the first described patient in whom the presence of autoantibodies precedes the manifestation of limbic encephalitis for many years. At the age of 38 years, in the serum of a patient with polyendocrine autoimmunity high titers of cytoplasmic islet cell antibodies and of anti-glutamate decarboxylase (GAD) 65 antibodies were observed as an incidential finding, GAD67 antibodies were negative at that time. After a latency of 18 years, she manifested with refractory temporal lobe epilepsy most likely due to autoimmune limbic encephalitis. After epilepsy onset, the patient underwent magnetic resonance imaging (MRI), electroencephalography, cerebrospinal fluid (CSF), serum and neuropsychological investigations during a follow-up period of 8 years. A pharmacoresistent epilepsy with seizure onset from the right temporal lobe and declarative memory deficits were observed affecting primarily the recall of verbal informations. MRI showed a slightly increased signal in the right amygdala without progression. GAD antibodies could be detected in serum (titre 1: 1000) and CSF (titre 1:1) by immunofluorescence. Both, GAD65 and GAD67 antibodies were observed in cell-based assays. It can be assumed that in addition to a pre-existing systemic T-cell response associated with the longstanding polyendocrine autoimmunity, a delayed intrathecal autoimmunity developed leading to limbic encephalitis. This change might be reflected by the development of GAD67 antibodies in our patient. Besides the contribution of this case report to a better understandig of the pathomechanisms for the development of central nervous system (CNS) autoimmunity, it also has a clinical impact as early treatment of GAD antibody-associated CNS disorders has a better prognosis. Therefore, vigilance for symptoms indicating GAD antibody-associated CNS autoimmunity is mandatory in patients with GAD antibody-associated endocrine dysfunction.

1 March 2006 in Psychiatry Research: Neuroimaging
Verified
Journal Article
Closed access
IUIngo Uttner
Ingo Uttner
FMFelix M. Mottaghy
Felix M. Mottaghy
HSHerbert Schreiber
Herbert Schreiber
ARAxel Riecker
Axel Riecker
ALAlbert C. Ludolph
Albert C. Ludolph
JKJan Kassubek
Jan Kassubek

29 June 2007 in European Neurology
Verified
Journal Article
Closed access
PDF file
IUIngo Uttner
Ingo Uttner
SWS. Weber
S. Weber
WFW. Freund
W. Freund
BSB. Schmitz
B. Schmitz
MRM. Ramspott
M. Ramspott
RHR. Huber
R. Huber
Transient global amnesia (TGA) is a clinical syndrome of unknown etiology characterized by sudden onset anterograde amnesia, which was thought to resolve completely. However, some authors have also suggested permanent memory impairment. It is unclear whether these results reflect a true persistent damage or a simply too short assessment interval in the context of a prolonged recovery phase after TGA. To evaluate the cognitive long-term outcome, 16 patients who had suffered from TGA at a mean of 3 years before and 15 healthy controls underwent a comprehensive neuropsychological test battery. No significant differences between patients’ and controls’ cognitive performance were found, irrespectively of the analyzed neuropsychological domain. Therefore we hypothesize that TGA usually does not cause persistent cognitive deficits due to a generally transient and prognostic benign character.

18 November 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
DTDaniela Taranu
Daniela Taranu
Hayrettin TumaniHayrettin Tumani
Hayrettin Tumani
JHJill Holbrook
Jill Holbrook
VTVisal Tumani
Visal Tumani
IUIngo Uttner
Ingo Uttner
PFPatrick Fissler
Patrick Fissler
Tracking cognition in patients with multiple sclerosis (MS) is important for detection of disease progression but it is often not performed in routine settings due to time constraints. This exploratory cohort study aims to develop a very brief repeatable tracking tool with comparable test quality criteria to the current gold standard, the Brief International Cognitive Assessment for MS (BICAMS). The study included 88 participants (22 healthy controls, 66 MS patients) who were examined at baseline and at one-year follow-up. As a validity criterion for the six administered cognitive tests, we assessed the difference between MS patients and HC, and the correlation with MS-related disability. Combining the two tests with the highest validity—the Controlled Oral Word Association Test and Symbol Digit Modalities Test—yielded an administration time of 5 min. Comparing this new TRACK-MS test battery with the 15 min BICAMS indicated that TRACK-MS showed larger differences between MS patients and healthy controls, a higher correlation with MS-related disability, smaller practice effects, and a good test–retest reliability. We provide evidence that TRACK-MS, although faster to administer, showed at least comparable quality criteria as the BICAMS. As the study was exploratory, replication of these results is necessary.

29 December 2010 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
IUIngo Uttner
Ingo Uttner
SWS. Weber
S. Weber
WFW. Freund
W. Freund
DBD. Bengel
D. Bengel
BSB. Schmitz
B. Schmitz
RHR. Huber
R. Huber